Sponsor:
Canadian Urology Research Consortium
Code:
NCT02936258
Conditions
Prostate Cancer
Eligibility Criteria
Sex: Male
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Standard of Care
MRI
MRI Targeted Biopsy
Brief summary:
Conditions
Prostate Cancer
Study ID
NCT02936258
Start date
Nov, 2016
Status verified date
Jan, 2018
Completion date
Nov, 2019
Anticipated
Primary completion date
Nov, 2019
Anticipated
Eligibility Criteria
Sex: Male
Age: 18+
Healthy Volunteers: Not accepted
Enrollment
450 participants
Anticipated
Allocation
Randomized
Intervention Model
Parallel Assignment
Primary purpose
Other
Arms
other: MRI
active comparator: Standard of Care
Interventions
Standard of Care
MRI
MRI Targeted Biopsy
Primary outcome measure
Central contacts
Locations
London Health Sciences Centre-Victoria Hospital
Recruiting
London, Ontario, Canada, N6A5W9
Contacts
Principal Investigator:
Joseph Chin, MD
Sunnybrook Health Sciences Centre
Recruiting
Toronto, Ontario, Canada, M4N 3M5
Contacts
Principal Investigator:
Laurence Klotz, MD
Princess Margaret Cancer Centre
Recruiting
Toronto, Ontario, Canada, M5G1X6
Contacts
Principal Investigator:
Antonio Finelli, MD
CIUSSS du Centre-Ouest-de-I'ile-de-Montreal-Jewish General Hospital
Recruiting
Montreal, Quebec, Canada, H3T1E2
Contacts
Principal Investigator:
Franck Bladou, MD
Sponsor
Canadian Urology Research Consortium
Last update posted
Feb 22, 2018
Last verified
Jan, 2018
Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-10. This information was provided to ClinicalTrials.gov by Canadian Urology Research Consortium on 2018-02-22.